Starpharma Holdings Limited

Starpharma Holdings Limitedverified

SPL.AX

Price:

$0.11

Market Cap:

$45.99M

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. It offers VivaGel, a non-antibiotic therapy for the treatment and prevention of bacterial vaginosis. The company also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, it develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase 2 clinical trials, DEP cabazitaxel that is in Phase 2 clinical trial, DEP gemcitabine that is in a Phase 1/2 clinical trials, and DEP irinotecan that is in Phase 2 clinical trials...[Read more]

Industry

Biotechnology

IPO Date

2000-09-27

Stock Exchange

ASX

Ticker

SPL.AX

The Enterprise Value as of January 2025 (TTM) for Starpharma Holdings Limited (SPL.AX) is 26.16M

According to Starpharma Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 26.16M. This represents a change of -69.86% compared to the average of 86.78M of the last 4 quarters.

Starpharma Holdings Limited (SPL.AX) Historical Enterprise Value (quarterly & annually)

How has SPL.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Starpharma Holdings Limited over the last ten years is 269.09M. The current 26.16M Enterprise Value has changed 872.16% with respect to the historical average. Over the past ten years (40 quarters), SPL.AX's Enterprise Value was at its highest in in the June 2021 quarter at 547.75M. The Enterprise Value was at its lowest in in the June 2017 quarter at -61118000.00.

Quarterly (TTM)
Annual

Average

269.09M

Median

232.38M

Minimum

17.73M

Maximum

530.65M

Starpharma Holdings Limited (SPL.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Starpharma Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 82.98%

Maximum Annual Enterprise Value = 530.65M

Minimum Annual Increase = -81.20%

Minimum Annual Enterprise Value = 17.73M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202417.73M-81.20%
202394.29M-63.33%
2022257.12M-51.55%
2021530.65M38.07%
2020384.34M-14.01%
2019446.97M17.64%
2018379.94M82.98%
2017207.64M17.58%
2016176.60M-9.72%
2015195.60M38.72%

Starpharma Holdings Limited (SPL.AX) Average Enterprise Value

How has SPL.AX Enterprise Value performed in the past?

The current Enterprise Value of Starpharma Holdings Limited (SPL.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

123.05M

5-year avg

256.83M

10-year avg

269.09M

Starpharma Holdings Limited (SPL.AX) Enterprise Value vs. Peers

How is SPL.AX’s Enterprise Value compared to its peers?

Starpharma Holdings Limited’s Enterprise Value is less than Mesoblast Limited (2.05B), less than Medical Developments International Limited (42.12M), greater than Pharmaxis Ltd (13.09M), less than Nanosonics Limited (823.79M), less than Mayne Pharma Group Limited (299.23M),

Build a custom stock screener for Starpharma Holdings Limited (SPL.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Starpharma Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Starpharma Holdings Limited (SPL.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Starpharma Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Starpharma Holdings Limited's Enterprise Value?

What is the highest Enterprise Value for Starpharma Holdings Limited (SPL.AX)?

What is the 3-year average Enterprise Value for Starpharma Holdings Limited (SPL.AX)?

What is the 5-year average Enterprise Value for Starpharma Holdings Limited (SPL.AX)?

How does the current Enterprise Value for Starpharma Holdings Limited (SPL.AX) compare to its historical average?